skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Chimeric OspA genes, proteins and methods of use thereof

Patent ·
OSTI ID:1422826

The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.

Research Organization:
Research Foundation of the State University of New York, Amherst, NY; Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
DE-SC0012704
Assignee:
Brookhaven Science Associates, LLC (Upton, NY)
Patent Number(s):
9,895,434
Application Number:
15/049,438
OSTI ID:
1422826
Resource Relation:
Patent File Date: 2016 Feb 22
Country of Publication:
United States
Language:
English

References (79)

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent January 2004
Gene Synthesis[New Synthetic Methods(77)] journal June 1989
Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab journal April 1997
Reshaping human antibodies: grafting an antilysozyme activity journal March 1988
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi journal April 1989
Recombinant constructs of Borrelia burgdorferi patent March 2006
Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA journal July 2005
[14] Protein biotinylation book January 1990
Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas patent August 1989
Effects of amino acid sequence changes on antibody-antigen interactions journal January 1994
Borrelia antigen patent November 1997
Method of making a projection viewable transparency comprising an electrostatographic toner image patent August 1993
Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information journal April 1994
Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis journal July 1998
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes journal May 1986
Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor journal August 2000
Genetic Analysis of Protein Stability and Function journal December 1989
Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry journal March 1997
Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons journal January 2000
Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes? journal January 1997
From genes to protein structure and function: novel applications of computational approaches in the genomic era journal January 2000
Antibodies that react with predetermined sites on proteins journal February 1983
Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process patent October 1989
Prodrugs of Peptides and Proteins for Improved Formulation and Delivery journal April 1993
Improved tools for biological sequence comparison. journal April 1988
Borrelia antigen patent July 2000
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. journal September 1979
Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents journal December 1996
Recombinant immunoglobin preparations patent March 1989
Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. journal January 1993
An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. journal January 1993
Compositions and methods for administering Borrelia burgdorferi antigens patent August 2006
Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus journal January 1991
A new technique for the assay of infectivity of human adenovirus 5 DNA journal April 1973
Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine journal June 1994
Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains. journal January 1994
Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi. journal January 1997
Borrelia burdorferi Osp A and B proteins and immunogenic peptides patent November 2000
Altered ospa of borrelia burgdorferi patent-application December 2009
By-passing immunisation journal September 1992
Reshaping human antibodies for therapy journal March 1988
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. journal November 1984
Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi
  • Luft, Benjamin J.; Dunn, John J.; Lawson, Catherine L.
  • The Journal of Infectious Diseases, Vol. 185, Issue s1, p. S46-S51 https://doi.org/10.1086/338463
journal February 2002
A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease journal July 1998
Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant journal July 1998
By-passing immunization: Human antibodies from V-gene libraries displayed on phage journal December 1991
Continuous cultures of fused cells secreting antibody of predefined specificity journal August 1975
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide journal July 1963
Preparation and use of polyethylene glycol propionaldehyde patent October 1993
Basic local alignment search tool journal October 1990
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. journal January 1996
A general method applicable to the search for similarities in the amino acid sequence of two proteins journal March 1970
OspA DNA and lyme disease vaccine patent February 2001
Comparison of biosequences journal December 1981
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs journal April 1990
The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi journal January 1995
Borrelia antigen patent March 2001
Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. journal July 1984
Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 patent July 1998
General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. journal August 1985
Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent August 1999
Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. journal January 1986
Non-immunogenic polypeptides patent December 1979
Replacing the complementarity-determining regions in a human antibody with those from a mouse journal May 1986
Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults journal December 1996
Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons journal January 1989
Immunometric assays using monoclonal antibodies patent March 1983
Humanized immunoglobulins patent December 1997
Structural identification of a key protective B-cell epitope in lyme disease antigen OspA journal October 2000
Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. journal January 1995
SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen journal March 1981
Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody journal June 2001
A comprehensive set of sequence analysis programs for the VAX journal January 1984
Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species journal August 1995
Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii journal October 1997
Amino acid substitution matrices from protein blocks. journal November 1992
Chimeric proteins comprising borrelia polypeptides and uses therefor patent June 2001
Applications and statistics for multiple high-scoring segments in molecular sequences. journal June 1993
Humanized immunoglobulins patent December 1996

Similar Records

Chimeric OspA genes, proteins and methods of use thereof
Patent · Tue Apr 19 00:00:00 EDT 2022 · OSTI ID:1422826

Recombinant constructs of Borrelia burgdorferi
Patent · Tue Feb 20 00:00:00 EST 2007 · OSTI ID:1422826

A New Approach to a Lyme Disease Vaccine
Journal Article · Tue Feb 01 00:00:00 EST 2011 · Clinical Infectious Diseases · OSTI ID:1422826

Related Subjects